Our Journey in Pharma

Kyodo International Corporation is an international Healthcare and Pharmaceutical company with offices, operations and branch offices in different countries. Established in the year 1980 Kyodo International Corporation has been synonymous with the Indian and Japanese pharma industry for over 3 decades.  Today we have an annual turnover of over Rs. 200 crores and is still growing.

 

Company’s core area of focus is contract manufacturing and supply of Active Ingredients and Pharmaceutical dosage forms to various innovator and generic companies across the globe. Its business operations and strategic initiatives are supported by robust Quality Management Systems, high class Regulatory approved infrastructure with unwavering commitment of Environment, Health and Safety. It helps Kyodo to offer its partners, Products & Services of highest level of cGMP, GLP & EHS standards. Today Kyodo is the partner of choice to many global Healthcare and Pharmaceutical companies, and it has created a standout name in the Healthcare and Pharmaceutical arena across geographies for its Value Addition, Reliability and Trust, backed up strong performance.

 

The company has strong business relationship with majority of the Japanese in addition to Indian pharmaceutical companies. The company has its offices in central Tokyo, Japan. Its Indian office, Kyodo India, was established in 1996 with branch offices in Delhi, Mumbai, Pune and Kerala. 

 

The organization has served numerous partners in their various pharma projects and businesses including multiple turnkey projects for innovator as well as generic companies in the Healthcare industry.  Kyodo has also been instrumental in supporting the Indian pharma industry by facilitating joint ventures and strategic collaborations with Japanese pharma companies for more than two decades.

 

Japan - the world’s second largest pharmaceutical market and India - the Pharmacy of the world, form the core focus markets to Kyodo. It has played major role in strategic collaborations between numerous major Japanese companies and many Indian organizations for production and supply of several lifesaving critical and emergency care drugs into these markets.

While India is still struggling to get into Japanese dosage form business board, we successfully completed site transfer of a Japanese innovator dosage form production to one of the leading Indian pharmaceutical giants. Kyodo also developed and commercialized various generic dosage form businesses, which continues till date.

 

We have pioneered Strategic Licensing out of Japanese and Indian dosage form to Generic partners in many countries as well. Our contract manufacturing area involves hazardous chemistry and difficult chemistry reactions in the Indian soil.

With its vast experience and knowledge in healthcare sector, the group has expanded its pharmaceutical activities and business to other major markets including Europe, Australia, China, Korea, Middle East and South America. It has contributed immensely to the world in terms of making accessible high-quality innovator new chemical entities and affordable generic products across various topographies. 

We offer growing portfolio products, including prescription Generic - generic, Branded generic, Biosimilar drugs, as well as over the counter (OTC) drugs present in widespread therapeutic segments including, but not limited to:

  • Urology

  • Cardiovascular

  • Respiratory and Acute Care

  • Infectious Disease

  • Dermatology

  • CNS

  • Women Healthcare

  • Vitamins

  • Oncology

 

One of the other key attributes of Kyodo is its technical expertise and strategic involvement in setting up large production units, technology transfer and subsequent marketing/sales partnerships in various countries. Kyodo not only plays a part in smooth execution of such collaborations but also is an integral part of forging new strategical alliances and groundbreaking new pharmaceutical technologies. Its business ideology of identifying complementary strengths, utilizing it to the maximum and continuous enhancement results in strengthening of its market presence and industry relationships.

 

We are the first company to bring a Japanese innovator company to India. This was done at a time when India was still incredibly young in the pharma industry. Tech transfer was done by us for a key intermediate for the innovator drug molecule, involving difficult reaction steps. We have also been the official distributor for the Japanese innovator drug and its licensing/distribution to some Asian companies.

 

Kyodo also has strong partners in Hospital and Medical equipment sector. The company supplies and maintains such products in various Indian hospitals.

 

Some of our clientele in India include Cipla, Dr. Reddy's, Sun Pharma, Shilpa Medicare, Solara, Aurore, Strides, Arcolab, Melody Healthcare, Mankind Pharma, Unimax Chemicals We work with many reputable clients in Japan as well, to name a few, Fujifilm Toyama Chemical, Takeda, Daichi Sankyo, Dainippon Sumitomo, Ono Pharmaceutical, Sawai Pharmaceutical, Choseido Pharmaceutical, Hisamitsu Pharmaceutical, Taisho Pharmaceutical, Yoshindo, Kyowa Pharmaceutical, Taiho, Yakult etc.